A multicentre, open-label, single-arm phase II trial of the efficacy and safety of sclerotherapy using 3% polidocanol foam to treat second-degree haemorrhoids (SCLEROFOAM)

被引：0

作者：

G. Gallo

R. Pietroletti

E. Novelli

A. Sturiale

R. Tutino

P. Lobascio

R. Laforgia

E. Moggia

M. Pozzo

M. Roveroni

V. Bianco

A. Realis Luc

A. Giuliani

E. Diaco

G. Naldini

M. Trompetto

R. Perinotti

G. Sammarco

机构：

[1] University of Catanzaro,Department of Medical and Surgical Sciences

[2] University of L’Aquila,Proctology Unit, Department of Biotechnological and Applied Clinical Sciences

[3] Biostat Research S.a.S,Proctology and Pelvic Floor Clinical Centre

[4] Cisanello University Hospital,Chirurgia 1

[5] Azienda ULSS 2 Marca Trevigiana,Surgical Unit “M. Rubino” Department of Emergency and Organ Transplantation

[6] Ospedale Regionale Treviso,Department of General Surgery

[7] University Aldo Moro of Bari,Department of General Surgery

[8] Infermi Hospital,Department of Surgery

[9] “Degli Infermi” Hospital,General Surgery Unit

[10] Aosta Hospital,Department of Colorectal Surgery

[11] Cetraro Hospital,General Surgery Unit, Department of Biotechnological and Applied Clinical Sciences

[12] S. Rita Clinic,Department of Health Sciences

[13] San Salvatore Hospital,Department of Medicine, Surgery and Neurosciences, Unit of General Surgery and Surgical Oncology

[14] University of L’Aquila,undefined

[15] Minerva Surgical Service,undefined

[16] University of Catanzaro,undefined

[17] University of Siena,undefined

来源：

Techniques in Coloproctology | 2022年 / 26卷

关键词：

Haemorrhoidal disease; Polidocanol foam; Safety; Sclerotherapy; Bleeding haemorrhoids;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：627 / 636

页数：9

共 50 条

[1] A multicentre, open-label, single-arm phase II trial of the efficacy and safety of sclerotherapy using 3% polidocanol foam to treat second-degree haemorrhoids (SCLEROFOAM)
Gallo, G.
Pietroletti, R.
Novelli, E.
Sturiale, A.
Tutino, R.
Lobascio, P.
Laforgia, R.
Moggia, E.
Pozzo, M.
Roveroni, M.
Bianco, V.
Luc, A. Realis
Giuliani, A.
Diaco, E.
Naldini, G.
Trompetto, M.
Perinotti, R.
Sammarco, G.
TECHNIQUES IN COLOPROCTOLOGY, 2022, 26 (08) : 627 - 636
[2] A MULTICENTER PHASE II TRIAL ON THE EFFICACY AND SAFETY OF SCLEROTHERAPY USING 3% POLIDOCANOL FOAM TO TREAT SECOND-DEGREE HEMORRHOIDAL DISEASE.
Gallo, G.
Sammarco, G.
Trompetto, M.
DISEASES OF THE COLON & RECTUM, 2022, 65 (05) : 25 - 25
[3] Sclerotherapy with 3% polidocanol foam to treat second-degree haemorrhoidal disease: Three-year follow-up of a multicentre, single arm, IDEAL phase 2b trial
Gallo, Gaetano
Picciariello, Arcangelo
Pietroletti, Renato
Novelli, Eugenio
Sturiale, Alessandro
Tutino, Roberta
Laforgia, Rita
Moggia, Elisabetta
Pozzo, Mauro
Roveroni, Maurizio
Bianco, Vincenzo
Luc, Alberto Realis
Giuliani, Antonio
Diaco, Elia
Naldini, Gabriele
Trompetto, Mario
Perinotti, Roberto
D'Andrea, Vito
Lobascio, Pierluigi
COLORECTAL DISEASE, 2023, 25 (03) : 386 - 395
[4] Efficacy and safety of levoketoconazole in the treatment of endogenous Cushing's syndrome (SONICS): a phase 3, multicentre, open-label, single-arm trial
Fleseriu, Maria
Pivonello, Rosario
Elenkova, Atanaska
Salvatori, Roberto
Auchus, Richard J.
Feelders, Richard A.
Geer, Eliza B.
Greenman, Yona
Witek, Przemyslaw
Cohen, Fredric
Biller, Beverly M. K.
LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (11): : 855 - 865
[5] Efficacy and safety of nivolumab in combination with ipilimumab in Japanese patients with advanced melanoma: An open-label, single-arm, multicentre phase II study
Namikawa, Kenjiro
Kiyohara, Yoshio
Takenouchi, Tatsuya
Uhara, Hisashi
Uchi, Hiroshi
Yoshikawa, Shusuke
Takatsuka, Sumiko
Koga, Hiroshi
Wada, Naoko
Minami, Hironobu
Hatsumichi, Masahiro
Asada, Suguru
Namba, Yoshinobu
Yamazaki, Naoya
EUROPEAN JOURNAL OF CANCER, 2018, 105 : 114 - 126
[6] Efficacy and safety of minocycline in retinitis pigmentosa: a prospective, open-label, single-arm trial
Chen, Yuxi
Pan, Yuan
Xie, Yanyan
Shi, Yuxun
Lu, Yao
Xia, Yiwen
Su, Wenru
Chen, Xiaoqing
Li, Zuoyi
Wang, Minzhen
Miao, Siyu
Yang, Yating
Jin, Chenjin
Luo, Guangwei
Long, Shixian
Xiao, Hui
Huang, Chuangxin
Zhang, Jian
Liang, Dan
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
[7] Safety and efficacy of oral fexinidazole in children with gambiense human African trypanosomiasis: a multicentre, single-arm, open-label, phase 2-3 trial
Kumesu, Victor Kande Betu
Kalonji, Wilfried Mutombo
Bardonneau, Clelia
Mordt, Olaf Valverde
Tete, Digas Ngolo
Blesson, Severine
Simon, Francois
Delhomme, Sophie
Bernhard, Sonja
Ngima, Pathou Nganzobo
Mbembo, Helene Mahenzi
Lubaki, Jean-Pierre Fina
Vuvu, Steven Lumeya
Mindele, Willy Kuziena
Kyhi, Medard Ilunga Wa
Mokenge, Guylain Mandula
Badibabi, Lewis Kaninda
Bonama, Augustin Kasongo
Lukula, Papy Kavunga
Lumbala, Crispin
Scherrer, Bruno
Strub-Wourgaft, Nathalie
Tarral, Antoine
LANCET GLOBAL HEALTH, 2022, 10 (11): : E1665 - E1674
[8] Efficacy and safety of Abelmoschus manihot in treating chronic kidney diseases: A multicentre, open-label and single-arm clinical trial
Sun, Xuefeng
Li, Ping
Lin, Hongli
Ni, Zhaohui
Zhan, Yongli
Cai, Guangyan
Liu, Chao
Chen, Qinkai
Wang, Wenge
Wang, Xiaoqin
Zhang, Peiqing
Li, Peng
Liang, Meng
Zheng, Hongguang
Wang, Niansong
Miao, Lining
Jin, Ruixia
Guo, Zhiyong
Wang, Yong
Chen, Xiangmei
PHYTOMEDICINE, 2022, 99
[9] Efficacy and Safety of Bavituximab in Combination with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Arm, Open-Label, Phase II Clinical Trial
Ali A. Mokdad
Hao Zhu
Muhammad S. Beg
Yull Arriaga
Jonathan E. Dowell
Amit G. Singal
Adam C. Yopp
Targeted Oncology, 2019, 14 : 541 - 550
[10] Efficacy and Safety of Bavituximab in Combination with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Arm, Open-Label, Phase II Clinical Trial
Mokdad, Ali A.
Zhu, Hao
Beg, Muhammad S.
Arriaga, Yull
Dowell, Jonathan E.
Singal, Amit G.
Yopp, Adam C.
TARGETED ONCOLOGY, 2019, 14 (05) : 541 - 550

← 1 2 3 4 5 →